Literature DB >> 28757389

Spatial organization of genome architecture in neuronal development and disease.

Yuki Fujita1, Toshihide Yamashita2.   

Abstract

Although mammalian genomes encode genetic information in their linear sequences, their fundamental function with regard to gene expression depends on the higher-order structure of chromosomes. Current techniques for the evaluation of chromosomal structure have revealed that genomes are arranged at several hierarchical levels in three-dimensional space. The spatial organization of genomes involves the formation of chromatin loops that bypass a wide range of genomic distances, providing a connection between enhancers and chromosomal domains. Furthermore, they form chromatin domains that are arranged into chromosome territories in the three-dimensional space of the cell nucleus. Recent studies have shown that the spatial organization of the genome is essential for normal brain development and function. Activity-dependent alterations in the spatial organization of the genome can regulate transcriptional activity related to neuronal plasticity. Disruptions in the higher-order chromatin architecture have been implicated in neuropsychiatric disorders, such as cognitive dysfunction and anxiety. Here, we discuss the growing interest in the role of genome organization in brain development and neurological disorders.
Copyright © 2017. Published by Elsevier Ltd.

Entities:  

Keywords:  3D genome; Chromatin loop; Chromosome; Cohesin; Nucleus

Mesh:

Substances:

Year:  2017        PMID: 28757389     DOI: 10.1016/j.neuint.2017.06.014

Source DB:  PubMed          Journal:  Neurochem Int        ISSN: 0197-0186            Impact factor:   3.921


  8 in total

Review 1.  Regulation and dysregulation of spatial chromatin structure in the central nervous system.

Authors:  Yuki Fujita
Journal:  Anat Sci Int       Date:  2021-01-03       Impact factor: 1.741

2.  Pericentromere clustering in Tradescantia section Rhoeo involves self-associations of AT- and GC-rich heterochromatin fractions, is developmentally regulated, and increases during differentiation.

Authors:  Hieronim Golczyk; Arleta Limanówka; Anna Uchman-Książek
Journal:  Chromosoma       Date:  2020-07-17       Impact factor: 4.316

Review 3.  Three-dimensional chromosome architecture and drug addiction.

Authors:  Javed M Chitaman; Peter Fraser; Jian Feng
Journal:  Curr Opin Neurobiol       Date:  2019-07-02       Impact factor: 6.627

Review 4.  Spatial genome exploration in the context of cognitive and neurological disease.

Authors:  Prashanth Rajarajan; Tyler Borrman; Will Liao; Sergio Espeso-Gil; Sandhya Chandrasekaran; Yan Jiang; Zhiping Weng; Kristen J Brennand; Schahram Akbarian
Journal:  Curr Opin Neurobiol       Date:  2019-06-27       Impact factor: 6.627

5.  Establishment of resveratrol and its derivatives as neuroprotectant against monocrotophos-induced alteration in NIPBL and POU4F1 protein through molecular docking studies.

Authors:  Ruchi Yadav; Prachi Srivastava
Journal:  Environ Sci Pollut Res Int       Date:  2019-11-30       Impact factor: 4.223

6.  Genome-wide identification of genic and intergenic neuronal DNA regions bound by Tau protein under physiological and stress conditions.

Authors:  Houda Benhelli-Mokrani; Zeyni Mansuroglu; Alban Chauderlier; Benoit Albaud; David Gentien; Sabrina Sommer; Claire Schirmer; Lucie Laqueuvre; Thibaut Josse; Luc Buée; Bruno Lefebvre; Marie-Christine Galas; Sylvie Souès; Eliette Bonnefoy
Journal:  Nucleic Acids Res       Date:  2018-11-30       Impact factor: 16.971

7.  Delineation of phenotypes and genotypes related to cohesin structural protein RAD21.

Authors:  Lianne C Krab; Iñigo Marcos-Alcalde; Melissa Assaf; Meena Balasubramanian; Janne Bayer Andersen; Anne-Marie Bisgaard; David R Fitzpatrick; Sanna Gudmundsson; Sylvia A Huisman; Tugba Kalayci; Saskia M Maas; Francisco Martinez; Shane McKee; Leonie A Menke; Paul A Mulder; Oliver D Murch; Michael Parker; Juan Pie; Feliciano J Ramos; Claudine Rieubland; Jill A Rosenfeld Mokry; Emanuela Scarano; Marwan Shinawi; Paulino Gómez-Puertas; Zeynep Tümer; Raoul C Hennekam
Journal:  Hum Genet       Date:  2020-03-19       Impact factor: 4.132

Review 8.  Developments in Biological Mechanisms and Treatments for Negative Symptoms and Cognitive Dysfunction of Schizophrenia.

Authors:  Qiongqiong Wu; Xiaoyi Wang; Ying Wang; Yu-Jun Long; Jing-Ping Zhao; Ren-Rong Wu
Journal:  Neurosci Bull       Date:  2021-07-05       Impact factor: 5.203

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.